Forbes October 27, 2023
Peter Ubel

Latuda is a drug to treat schizophrenia. It costs about $4,000 per month in the U.S. In Canada, the price is closer to $500.

Ibrance, a breast cancer drug, costs $10,000 more per month in the U.S. than in Canada.

Why these enormous price differences? For an answer to that question, consider another cancer. It is called metastatic cholangiocarcinoma. You probably know what the metastatic and the carcinoma parts of these words mean—that the cancer has spread beyond its origin. The “cholangio” part signifies the original location of the tumor: in the bile ducts, the slender tubes connecting your liver to your gallbladder and small intestine.

For people with distant metastases, when the cancer has spread far away from the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Pharma, Pharma / Biotech, Pricing / Spending
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article